Delivery Order SPE2DB24D2100-SPE2DB24FBCDW

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Bridion 200 mg/2 ml vial (2 ml). The contract is a firm fixed-price delivery order with a ceiling value of $16,154.29 and a period of performance through April 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bridion 200 mg/2 ml vials, a medical product used in healthcare settings. The contract has a firm fixed price of $32,395.69 and a period of performance through June 24, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,822.12 contract is for the supply of Bridion 200 mg/2 ml vial medication, with a period of performance through May 14, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,717.47, is for the delivery of Bridion 200mg/2ml, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bridion 200 mg/2 ml vials, a medical product used in healthcare settings. The contract has a firm-fixed price, a ceiling value of $21,152.85, and a period of performance ending on June 18, 2025. This delivery order is not designated as a set-aside contract, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,735.83 firm fixed-price contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 13, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bridion 200 mg/2 ml vial medical products. The contract has a ceiling value of $4,832.39 and a period of performance through October 19, 2023. The delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bridion 200mg/2ml, a pharmaceutical product, with a ceiling value of $34,244.12. The contract is a firm fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bridion 200 mg/2 ml vial (2 ml). The contract has a firm fixed price of $11,396.60 and a completion date of June 5, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Bridion 200 mg/2 mL vials. The delivery order, valued at $6,842.72, is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCDW
    Delivery Order

This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Bridion 200 mg/2 ml vials. The contract has a firm fixed price of $45,520.78 and a completion date of June 28, 2024. It is not designated as a set-aside contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is likely a task order under this larger IDC framework.

Generated 5/17/25, 9:47 AM